D. Dongiovanni

发表

Predicting gefitinib responsiveness in lung cancer by fluorescence in situ hybridization/chromogenic in situ hybridization analysis of EGFR and HER2 in biopsy and cytology specimens

A. Sapino, L. Bonello, M. Schena, 2007, Molecular Cancer Therapeutics.

Cisplatin and Gemcitabine in Malignant Pleural Mesothelioma: A Phase II Study

S. Bretti, B. Castagneto, G. Numico, 2005, American journal of clinical oncology.

Sequential chemotherapy of cisplatin and vinorelbine followed by paclitaxel and gemcitabine in advanced non-small-cell lung cancer. A single institution phase II study.

A. Addeo, O. Bertetto, A. Berruti, 2005, Lung cancer.

A phase II trial of weekly paclitaxel and gemcitabine in non-small cell lung cancer patients previously treated with platinum and vinorelbine.

A. Addeo, O. Bertetto, A. Berruti, 2004, Anticancer research.

Weekly cisplatin paclitaxel and continuous infusion fluorouracil in patients with recurrent and/or metastatic head and neck squamous cell carcinoma: a phase II study

M. Schena, O. Bertetto, C. Barone, 2005, Cancer Chemotherapy and Pharmacology.

Induction chemotherapy followed by concurrent chemoradiotherapy in advanced head and neck squamous cell carcinoma.

S. Berrone, P. Garzino-Demo, U. Ricardi, 2008, Anticancer research.

Second-line chemotherapy with weekly paclitaxel and gemcitabine in patients with small-cell lung cancer pretreated with platinum and etoposide: a single institution phase II trial

A. Addeo, O. Bertetto, A. Berruti, 2006, Cancer Chemotherapy and Pharmacology.

Fractionated dose of cisplatin (CDDP) and vinorelbine (VNB) chemotherapy for elderly patients with advanced non-small cell lung cancer: phase II trial.

M. Schena, O. Bertetto, L. Buffoni, 2006, Lung cancer.

Gefitinib (ZD1839): therapy in selected patients with non-small cell lung cancer (NSCLC)?

A. Sapino, A. Addeo, M. Schena, 2008, Lung cancer.